Bullboard - Stock Discussion Forum Merus NV MRUS

Healthcare Biotechnology

Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's... see more

Add To Watchlist

NDAQ:MRUS - Post Discussion

Merus NV > Merus Announces First Patient Dosed in LiGeR-HN1, a Phase 3

View:

Post by whytestocks on Sep 30, 2024 1:17pm

Merus Announces First Patient Dosed in LiGeR-HN1, a Phase 3

Just In: $MRUS Merus Announces First Patient Dosed in LiGeR-HN1, a Phase 3 Trial Evaluating Petosemtamab in Combination with Pembrolizumab in 1L r/m HNSCCUTRECHT, The Netherlands and CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and Triclonics ® ), today ...MRUS - Merus Announces First Patient Dosed in LiGeR-HN1, a Phase 3 Trial Evaluating Petosemtamab in Combination with Pembrolizumab in 1L r/m HNSCC

556